Mirion Technologies, Inc. (New York Stock Exchange:MIR)
| Market Cap | 3.88B-32.9% |
| Revenue (ttm) | 1.02B+15.7% |
| Net Income | 24.50M+145.0% |
| EPS | 0.09+118.2% |
| Shares Out | 243.28M |
| PE Ratio | 161.92 |
| Forward PE | 23.92 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,093,740 |
| Open | 16.20 |
| Previous Close | 16.45 |
| Day's Range | 15.87 - 16.26 |
| 52-Week Range | 14.04 - 30.28 |
| Beta | 1.10 |
| Analysts | Buy |
| Price Target | 23.00(+44.07%) |
| Earnings Date | Oct 27, 2026 |
Mirion Technologies, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About MIR
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$MIR stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in MIR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MIR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MIR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
MIR Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Nuclear & Safety | $186.20M | 69.79% |
| Medical | $80.60M | 30.21% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New MIR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MIR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in MIR
| ETF | Est. Holding Size |
|---|---|
| IJRiShares Core S&P Small-Cap ETF | $239.21M |
| VTIVanguard Morningstar Total Stock Market ETF | $111.37M |
| IWMiShares Russell 2000 ETF | $104.59M |
| VBVanguard Morningstar Small-Cap ETF | $80.55M |
| VGTVanguard Information Technology ETF | $77.84M |
| VBRVanguard Morningstar Small-Cap Value ETF | $51.18M |
Estimated from each fund’s disclosed top holdings × AUM
MIR Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from MIR’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score